4 Mucolytics and Airway Secretion Management
Learn how mucus-thinning medicines, expectorants, and airway clearance techniques support secretion removal, and how to account for important safety considerations.
How secretion management works
Airway secretion management combines treatments that change mucus so it is easier to move with techniques that help remove it. These approaches are used in selected conditions, including cystic fibrosis (CF) and bronchiectasis; the appropriate treatment depends on the patient’s condition and care plan.
Mucus-thinning medicines change secretion properties, help loosen mucus, and airway clearance techniques help move secretions out of the airways. Effective clearance is especially important when treatment loosens or increases secretions.
Mucus-thinning medicines
is an inhaled mucolytic that reduces mucus viscosity by disrupting disulfide bonds. It can increase the volume of loosened secretions, so an effective cough or another means of clearing the airway is important. A weak cough can make it harder to clear these more abundant, mobile secretions.
Inhaled can cause . Monitor for worsening airway obstruction and follow the prescribed plan. New wheezing during treatment calls for assessment and the prescribed clinical response; worsening obstruction needs prompt attention.
is a recombinant DNase that cuts extracellular DNA in purulent CF sputum, reducing its viscosity. It does not work by relaxing airway smooth muscle, suppressing the cough reflex, or directly killing bacteria.
helps hydrate airway mucus and support its clearance. is another mucus-clearance therapy, used in eligible adults with CF. Because it can cause , its prescribing and use require appropriate clinical screening and precautions.
and symptom relief
, such as guaifenesin, help loosen mucus so it is easier to cough up. Guaifenesin can provide symptom relief, but it does not treat the underlying cause of illness; it does not cure a bacterial infection or prevent airway inflammation.
Airway clearance and care planning
help move secretions so they can be removed from the airways. They include huff coughing, active-cycle breathing, positive expiratory pressure (PEP) devices, chest physical therapy, and oscillatory vests. A PEP device supports secretion movement through breathing technique and expiratory resistance.
Hydration may also help keep mucus less thick. A care team may coordinate a bronchodilator, mucus-thinning treatment, an ACT, and—in some CF regimens—inhaled antibiotics. Follow the individual treatment plan rather than assuming that one sequence suits everyone.